# THC Therapeutics, Inc. (THCT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/THCT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 0 | $ -556.9K | $ -191.8K | $ 731.8K | $ -3.42M |
| 2023 | $ 0 | $ -2.61M | $ -92.4K | $ 791.4K | $ -3.31M |
| 2022 | $ 0 | $ -1.28M | $ -468.0K | $ 801.0K | $ -3.11M |
| 2021 | $ 0 | $ -2.24M | $ -461.8K | $ 761.3K | $ -2.48M |
| 2020 | $ 0 | $ -2.45M | $ -749.0K | $ 430.0K | $ -1.78M |
| 2019 | $ 0 | $ -30.08M | $ -425.7K | $ 177.6K | $ -749.4K |
| 2018 | $ 0 | $ -8.02M | $ -251.9K | $ 176.2K | $ 1.94M |
| 2017 | $ 0 | $ -21.01M | $ -238.1K | $ 82.7K | $ 4.85M |
| 2016 | $ 0 | $ -126.6K | $ -23.8K | $ 181.1K | $ -144.5K |
| 2015 | $ 0 | $ -399.2K | $ -16.7K | $ 170.0K | $ -277.5K |
| 2014 | $ 0 | $ -814.0K | $ -129.7K | $ 157.5K | $ -188.5K |
| 2013 | $ 0 | $ -1.61M | $ -158.2K | $ 58.0K | $ 47.1K |
| 2012 | $ 0 | $ -348.7K | $ -379.1K | $ 0 | $ 206.0K |
| 2011 | $ 0 | $ -36.4K | $ 0 | $ 20.0K | $ -64.9K |
| 2010 | $ 0 | $ -56.8K | $ -211.5K | $ 20.0K | $ -40.2K |
| 2009 | $ 0 | $ -104.3K | $ 0 | $ 1.0K | $ -68.5K |
| 2008 | $ 0 | $ -12.9K | $ -13.2K | $ 1.0K | $ 7.6K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.21 |
| Liabilities / Eq | -1.03 |
| Current Ratio | 0.00 |

## Other views

- [Metrics](https://sponda.capital/en/THCT.md)
- [Charts](https://sponda.capital/en/THCT/charts.md)
- [Compare](https://sponda.capital/en/THCT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.